Forte Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	93.41	22.24	37.13	41.1	42.04	58.77
Short-Term Investments	-	36.12	-	-	-	-
Cash & Short-Term Investments	93.41	58.37	37.13	41.1	42.04	58.77
Cash Growth	470.89%	57.21%	-9.67%	-2.25%	-28.45%	746.88%
Prepaid Expenses	1	2.65	1.04	0.34	0.39	0.96
Other Current Assets	0.47	0.34	0.17	0.07	0.09	0.18
Total Current Assets	95.41	61.35	38.33	41.51	42.52	59.9
Property, Plant & Equipment	0.15	0.08	0.11	-	-	0.1
Long-Term Deferred Charges	-	-	-	-	0.11	0.29
Other Long-Term Assets	1.53	0.14	0.54	0.49	0.68	0.96
Total Assets	97.09	61.56	38.98	42	43.31	61.24
Accounts Payable	5.49	4.88	1.42	1.15	0.95	1.24
Accrued Expenses	7.5	4.2	2.24	2.03	0.81	1.02
Total Current Liabilities	12.99	9.08	3.67	3.18	1.76	2.26
Total Liabilities	12.99	9.08	3.67	3.18	1.76	2.26
Common Stock	0.01	0.01	0	0.02	0.02	0.01
Additional Paid-In Capital	282.68	206.46	153.83	125.84	114.7	110.42
Retained Earnings	-198.59	-154	-118.52	-87.04	-73.17	-51.46
Comprehensive Income & Other	-0.01	0.01	0	-	-	-
Total Common Equity	84.1	52.48	35.31	38.82	41.55	58.98
Shareholders' Equity	84.1	52.48	35.31	38.82	41.55	58.98
Total Liabilities & Equity	97.09	61.56	38.98	42	43.31	61.24
Net Cash (Debt)	93.41	58.37	37.13	41.1	42.04	58.77
Net Cash Growth	470.89%	57.21%	-9.67%	-2.25%	-28.45%	746.88%
Net Cash Per Share	7.93	20.02	29.40	59.11	75.25	199.64
Filing Date Shares Outstanding	12.53	6.58	1.46	0.84	0.59	0.54
Total Common Shares Outstanding	17.83	6.39	1.45	0.84	0.59	0.51
Working Capital	82.42	52.27	34.66	38.33	40.76	57.64
Book Value Per Share	4.72	8.21	24.30	46.21	70.40	114.92
Tangible Book Value	84.1	52.48	35.31	38.82	41.55	58.98
Tangible Book Value Per Share	4.72	8.21	24.30	46.21	70.40	114.92
Machinery	0.24	0.13	0.12	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q